BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 30483249)

  • 1. Natural Killer Cells Adapt to Cytomegalovirus Along a Functionally Static Phenotypic Spectrum in Human Immunodeficiency Virus Infection.
    Holder KA; Lajoie J; Grant MD
    Front Immunol; 2018; 9():2494. PubMed ID: 30483249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus-Driven Adaption of Natural Killer Cells in NKG2C
    Comeau EM; Holder KA; Fudge NJ; Grant MD
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30857329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cells generate memory-type responses to human cytomegalovirus-infected fibroblasts.
    Newhook N; Fudge N; Grant M
    Eur J Immunol; 2017 Jun; 47(6):1032-1039. PubMed ID: 28475279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NKG2C(+)CD57(+) Natural Killer Cell Expansion Parallels Cytomegalovirus-Specific CD8(+) T Cell Evolution towards Senescence.
    Heath J; Newhook N; Comeau E; Gallant M; Fudge N; Grant M
    J Immunol Res; 2016; 2016():7470124. PubMed ID: 27314055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late Development of FcεRγ
    Muccio L; Falco M; Bertaina A; Locatelli F; Frassoni F; Sivori S; Moretta L; Moretta A; Della Chiesa M
    Front Immunol; 2018; 9():1050. PubMed ID: 29868012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent cytomegalovirus infection enhances anti-tumour cytotoxicity through accumulation of NKG2C+ NK cells in healthy humans.
    Bigley AB; Rezvani K; Shah N; Sekine T; Balneger N; Pistillo M; Agha N; Kunz H; O'Connor DP; Bollard CM; Simpson RJ
    Clin Exp Immunol; 2016 Aug; 185(2):239-51. PubMed ID: 26940026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of NKG2C Copy Number with the Distribution of Distinct Cytomegalovirus-Induced Adaptive NK Cell Subsets.
    Muntasell A; Pupuleku A; Cisneros E; Vera A; Moraru M; Vilches C; López-Botet M
    J Immunol; 2016 May; 196(9):3818-27. PubMed ID: 26994220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection.
    Brunetta E; Fogli M; Varchetta S; Bozzo L; Hudspeth KL; Marcenaro E; Moretta A; Mavilio D
    AIDS; 2010 Jan; 24(1):27-34. PubMed ID: 19910789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive Reconfiguration of Natural Killer Cells in HIV-1 Infection.
    Peppa D; Pedroza-Pacheco I; Pellegrino P; Williams I; Maini MK; Borrow P
    Front Immunol; 2018; 9():474. PubMed ID: 29616021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Cytomegalovirus Antigen Presentation by HLA-DR+ NKG2C+ Adaptive NK Cells Specifically Activates Polyfunctional Effector Memory CD4+ T Lymphocytes.
    Costa-García M; Ataya M; Moraru M; Vilches C; López-Botet M; Muntasell A
    Front Immunol; 2019; 10():687. PubMed ID: 31001281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional and clinical consequences of changes to natural killer cell phenotypes driven by chronic cytomegalovirus infections.
    Lee S; Doualeh M; Affandi JS; Makwana N; Irish A; Price P
    J Med Virol; 2019 Jun; 91(6):1120-1127. PubMed ID: 30636352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus.
    Costa-Garcia M; Vera A; Moraru M; Vilches C; López-Botet M; Muntasell A
    J Immunol; 2015 Mar; 194(6):2715-24. PubMed ID: 25667418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK-cell responses are biased towards CD16-mediated effector functions in chronic hepatitis B virus infection.
    Schuch A; Zecher BF; Müller PA; Correia MP; Daul F; Rennert C; Tauber C; Schlitt K; Boettler T; Neumann-Haefelin C; Hengel H; Pircher H; Cerwenka A; Thimme R; Hofmann M
    J Hepatol; 2019 Mar; 70(3):351-360. PubMed ID: 30342116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic and functional analysis in HER2+ targeted therapy of human NK cell subpopulation according to the expression of FcεRIγ and NKG2C in breast cancer patients.
    Bordignon MB; Pesce Viglietti AI; Juliá EP; Sanchez MB; Rölle A; Mandó P; Sabatini L; Ostinelli A; Rizzo MM; Barrio MM; Mordoh J; Fainboim L; Levy EM
    Cancer Immunol Immunother; 2023 Aug; 72(8):2687-2700. PubMed ID: 37081323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood.
    Della Chiesa M; Falco M; Bertaina A; Muccio L; Alicata C; Frassoni F; Locatelli F; Moretta L; Moretta A
    J Immunol; 2014 Feb; 192(4):1471-9. PubMed ID: 24442432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytomegalovirus IL-10 augments NK cell cytotoxicity.
    Holder KA; Grant MD
    J Leukoc Biol; 2019 Aug; 106(2):447-454. PubMed ID: 30964577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robust 8-color flow cytometry panel reveals enhanced effector function of NKG2C
    Nerreter T; Zeiß S; Herrmann T; Einsele H; Seggewiss-Bernhardt R
    Immunobiology; 2017 May; 222(5):719-725. PubMed ID: 28139257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals.
    Kristensen AB; Wragg KM; Vanderven HA; Lee WS; Silvers J; Kent HE; Grant MD; Kelleher AD; Juno JA; Kent SJ; Parsons MS
    Clin Exp Immunol; 2022 Dec; 210(2):163-174. PubMed ID: 36053502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive NKG2C
    Kared H; Martelli S; Tan SW; Simoni Y; Chong ML; Yap SH; Newell EW; Pender SLF; Kamarulzaman A; Rajasuriar R; Larbi A
    Front Immunol; 2018; 9():686. PubMed ID: 29731749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adaptive Features of Natural Killer Cells in Multiple Sclerosis.
    Moreira A; Alari-Pahissa E; Munteis E; Vera A; Zabalza A; Llop M; Villarrubia N; Costa-García M; Álvarez-Lafuente R; Villar LM; López-Botet M; Martínez-Rodríguez JE
    Front Immunol; 2019; 10():2403. PubMed ID: 31681293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.